Latest Commercialization News

Athena Resources has partnered with Warradarge Energy and Fenix Resources to launch the Mid West Green Iron Project, aiming to produce sustainable green iron using ultra-high-grade magnetite and renewable hydrogen in Western Australia.

Pacific Edge reports steady demand for its Cxbladder cancer diagnostic tests despite losing Medicare coverage and transitioning US customers to a new test. The company is advancing clinical evidence and a $21 million capital raise to support growth and regain coverage.

Bio-Gene Technology Limited has announced an offer of over 95 million Placement Options to investors and its Lead Manager, contingent on shareholder approval at an upcoming extraordinary general meeting. If exercised, these options could inject approximately $3.8 million into the company.

BMG Resources confirms a substantial gold system at its Abercromby Gold Project through Phase 1 drilling results, validating its geological model and setting the stage for resource expansion. The company is advancing plans for Phase 2 drilling and a scoping study to explore commercial mining potential.

Tissue Repair Limited has secured major distribution partnerships in Australia, New Zealand, and Thailand for its TR Pro+® product line, marking a pivotal shift from development to commercialisation. The company is also scaling up manufacturing and advancing regulatory approvals to support its global expansion ambitions.

Almonty Industries has released an updated JORC technical report for its Sangdong Tungsten Mine, affirming Phase I production commencement in late 2025 and outlining plans for a fully permitted Phase II expansion to double throughput.

Bryah Resources has exercised its option to acquire the Golden Pike gold and antimony project in New Brunswick, Canada, aiming to add significant value with a high-grade resource. The acquisition follows thorough due diligence and complements Bryah’s existing Australian portfolio.

Service Stream Limited has extended its contract with NBN Co to continue upgrading the ACT’s fibre network, securing $360 million in revenue over 3.5 years.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing of Elate Ocular, a promising treatment for moderate to severe dry eye disease, pending additional financing.

Pharmx Technologies has extended its pivotal National Diabetes Services Scheme agreement and expanded its supplier base, reinforcing its leadership in pharmacy digital infrastructure across Australia and New Zealand.

Cromwell Property Group has launched a major office development in Canberra’s Barton precinct with a long-term lease to a key Commonwealth Government department, alongside a strategic debt refinancing.

Nanoveu Limited has raised A$2 million through a strategic placement to accelerate the commercialisation of its 16nm ECS-DoT chip and expand its EMASS modular AIoT platform, positioning the company for global growth.